Primary hepatocellular carcinoma (HCC) is a significant tumor worldwide and represents the most common primary hepatic neoplasm. Staging criteria are important for appreciation of timely work up of these neoplasms in contradiction with surgical colleagues. This article demonstrates the appearance of HCC on multiphasic, multidetector CT (MDCT) and relates these findings to current staging criteria. The variable appearance on different planes of contrast is critical to appreciate in staging this neoplasm. The hypervascular nature of the primary tumor makes MDCT and three-phase imaging a critical feature in the detection and characterization of this tumor. This is especially critical in the patients who are candidates for surgical resection. Additionally, MDCT has allowed arterial phase imaging to define the vascular supply of the tumor. An accurate representation of the size and number of lesions is critical in not only the initial staging but also the follow-up of hepatocellular carcinoma. The post-treatment features including the appearance post-surgically and after radiofrequency ablation can be well appreciated on MDCT.

Author

Paul M Silverman and Janio Szklaruk

Contact Details

Corresponding address:
Paul M Silverman, MD,
Department of Radiology,
University of Texas M. D. Anderson Cancer Center,
Houston, TX, USA.

Reference

ICIS Cancer Imaging Volume 5 Issue 1
DOI: 10.1102/1470-7330.2005.0105

Date Posted

10 December 2005

Screen PDF

Size

961.95 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	3 seconds
ADSL 512Kb/s (Broadband):	15 seconds
64 Kb/s (ISDN):	2 minutes 0 seconds
33.3 Kb/s (Typical Modem):	3 minutes 51 seconds

Print PDF

Size

31.79 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	2 minutes 7 seconds
ADSL 512Kb/s (Broadband):	8 minutes 28 seconds
64 Kb/s (ISDN):	1 hour 7 minutes 48 seconds
33.3 Kb/s (Typical Modem):	2 hours 10 minutes 20 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.